FDA Inspection 1146260 — Reprise Biomedical, Inc.
The FDA completed an inspection of Reprise Biomedical, Inc. on July 8, 2021 in Plymouth, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 8, 2021
- Fiscal Year
- 2021
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Plymouth, MN (United States)